pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-liste ...
…
continue reading
1
Access to genomic surveillance: Open science and public health
18:28
18:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:28
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development. In today’s podcast, web editor Nicole Raleigh speaks with …
…
continue reading
1
Advancing Precision Care For All
27:42
27:42
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
27:42
Precision medicine is oft spoken about these days, as it is finally addressing the elephant in the room: one size – or, more appropriately, one dose – does not fit all. Precision medicine hones in on treatment of the individual, rather than just the disease, focusing on the reality that each patient is biologically different. Personalisation is ver…
…
continue reading
1
Investment outlook: Key takeaways from LSX USA
33:16
33:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
33:16
Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies. And so, it was no surprise that the 2024 LSX USA Congress in Boston attracted life sciences innovators and decision-makers from around the world, eager to explore the la…
…
continue reading
1
Oncology today: Eversana and pharmaphorum at ESMO 2024
18:44
18:44
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:44
The ESMO congress always disseminates the latest results of cancer research, a vibrant gathering and sharing of the latest data, communicating the next promising steps in oncological scientific development, ever seeking to address unmet patient needs. So it was that pharmaphorum Web Editor Nicole Raleigh found a quiet spot onsite in Barcelona this …
…
continue reading
1
Medicare drug pricing negotiations: What comes next?
28:32
28:32
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
28:32
Last month, the US Centers for Medicare and Medicaid Services released the negotiated prices for the first 10 drugs subject to the drug negotiation provisions in the Inflation Reduction Act. The industry has been waiting with bated breath to see these prices, as they give the first real indication of how impactful this unprecedented legislation wil…
…
continue reading
1
The Life Sciences Generative AI Council and a sustainable technological future
17:06
17:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
17:06
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpointing and showcasing repeatable use cases to shape the targeted use of next-generation artificial intelligence and machine learning (AI-ML) innovation, particularly…
…
continue reading
1
Can self-navigating ADCs replace chemotherapy in the future?
19:43
19:43
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:43
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brian Fiske, chief scientific officer of Mythic Therapeutics, about minimising side effects for patients and the notion of patient-centred science.Par pharmaphorum
…
continue reading
1
Structuring the unstructured: Deterministic AI and white box data cleanliness
18:31
18:31
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:31
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jane Reed, director of life sciences at Linguamatics, an IQVIA company, to discuss some of the major barriers preventing researchers from accessing the data they need to advance drug discovery and development and address safety concerns – and just how AI technologies can assist.…
…
continue reading
1
People need to know how to use AI now
31:19
31:19
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:19
With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well…
…
continue reading
1
Chronic cough and the patient voice
14:09
14:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:09
Chronic cough impacts up to 10% of the adult population and has a physical, psychological, and social impact on patients’ lives. Farrell Simon, chief commercial officer at Trevi Therapeutics, joins web editor Nicole Raleigh on the pharmaphorum podcast to discuss prioritising patients in clinical and commercial development, with an especial focus on…
…
continue reading
1
Approaching the regulatory world with passion: CERs and EU MDR processes
21:46
21:46
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:46
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ethan Drower, co-founder and CEO of Cite Medical Solutions, a company providing full Clinical Evaluation Report (CER) services and industry literature review for European Union Medical Device Regulation (or EU MDR) processes.Par pharmaphorum
…
continue reading
1
Patient engagement throughout the product lifecycle
28:34
28:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
28:34
One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list. Real patient engagement needs to be integrated into processes every step of the way. In today's podcast, brought to you by Reverba, Reverba CEO Cheryl Lubbert joins …
…
continue reading
1
The empowerment of data and predictive outcome models
21:32
21:32
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:32
In today’s podcast, web editor Nicole Raleigh speaks with Carolyn Ward, director of clinical strategy at Particle Health Inc, a data transformation platform for healthcare, enabling organisations across the care continuum to turn medical records into actionable insights.Par pharmaphorum
…
continue reading
1
The burden of diabetic vision loss in the West
17:24
17:24
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
17:24
In today’s podcast, web editor Nicole Raleigh welcomes Dr Catherine Beech, CEO of Exonate, for a discussion on retinal vascular disease and a potential eye drop treatment for diabetic retinopathy and diabetic macular oedema, instead of invasive injections into the eye.Par pharmaphorum
…
continue reading
1
Tips for on-time tech transfers that stay below budget
25:09
25:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
25:09
When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, presents many obstacles that have to be well thought out and planned. Delivering a tech transfer on schedule that stays below budget is no easy feat, but with the …
…
continue reading
1
Clinical trial trends and the rise of site networks
29:28
29:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
29:28
We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space. In today's podcast, brought to you by Advanced Clinical, host Jonah Comstock is joined by Jason Casarella, EVP of business development and marketing at Advanced Clinical and Caroline Redecker, chief strategy offi…
…
continue reading
1
A spectrum of obesity requires precision
23:47
23:47
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
23:47
In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.…
…
continue reading
1
The power and potential of regenerative medicine
20:02
20:02
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
20:02
The field of muscle stem cell research has been tangibly developing over the decades and in today’s pharmaphorum podcast wed editor Nicole Raleigh speaks with Dr Michael Rudnicki, co-founder and CSO of Satellos Biosciences, a company dedicated to developing novel therapeutics based on this science for those who live with Duchenne muscular dystrophy…
…
continue reading
1
Leveraging data and AI for clinical trial success
15:25
15:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:25
In today’s pharmaphorum podcast, Orr Inbar, co-founder and CEO of QuantHealth, a Tel Aviv-based AI-powered clinical trial design company, discusses how advances in data and AI can help.Par pharmaphorum
…
continue reading
1
The future of fertility and the vaginal microbiome
24:54
24:54
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
24:54
In a new episode of the pharmaphorum podcast - recorded back in March, during Women’s History Month - web editor Nicole Raleigh spoke with Johan van Hylckama Vlieg, co-founder and chief scientific officer of Freya Biosciences, a Series A-financed, clinical stage, microbial immunotherapy company in women’s health, discussing the role of the vaginal …
…
continue reading
1
Sustainable innovation for patients, people, and planet
29:13
29:13
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
29:13
Sustainability is all important for the planet and its people, and in today’s podcast web editor Nicole Raleigh speaks with Harriet Lewis, director of public affairs and communications at Chiesi UK & Ireland, about how partnerships between the NHS and pharma industry can support the journey to more sustainable practices, from R&D and drug reimburse…
…
continue reading
1
The new frontier of microbiome-directed human health
30:47
30:47
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
30:47
The microbiome is ever more frequently spoken about of late, and so the pharmaphorum podcast invited Leo Grady, founder and CEO of Jona, to speak about at-home personal microbiome profiling, uncovering the relationship between human health and the gut.Par pharmaphorum
…
continue reading
1
Global medicines and the future outlook
28:39
28:39
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
28:39
In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the IQVIA Institute for Human Data Science, to discuss the state of global medicines and the future outlook when it comes to research and development, and usage and spending a…
…
continue reading
1
Purity, potency, and safety – affordably – in stem cell therapy
28:25
28:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
28:25
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.Par pharmaphorum
…
continue reading
In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Rob Pears, VP and head of automotive, manufacturing, and life sciences at Capgemini, which partners with companies to transform and manage their business by harnessing the power of technology.Par pharmaphorum
…
continue reading
1
Move over CAR-T: The potential of NK cells in cell therapy
34:31
34:31
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
34:31
On today’s podcast, Dr. Fred Aslan, CEO of Artiva Biosciences, joins host Jonah Comstock to talk more about this newer avenue in cell therapy. They discuss the potential of NK cells to provide effective allogeneic cell therapy, the potential of the therapy in auto-immune disease, and the importance of a robust manufacturing process that can get a h…
…
continue reading
1
Working for a mature form of genomic medicines
20:08
20:08
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
20:08
In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.Par pharmaphorum
…
continue reading
1
Challenges and opportunities in synthetic clinical trials
44:01
44:01
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
44:01
On today’s episode Web Sun, president and cofounder of Komodo Health and Tracy Mayne, SVP regulatory and life sciences research at Slipstream IT, talk about this trend, where the industry is now, and what they’re doing to move it along.Par pharmaphorum
…
continue reading
1
The commercialisation of quantum science in pharma
26:03
26:03
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
26:03
In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.Par pharmaphorum
…
continue reading
1
Conference report: Reuters Pharma Europe
37:25
37:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
37:25
In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the hot seat to discuss the biggest trends and talking points from last month’s Reuters Pharma Europe 2024 in Barcelona.Par pharmaphorum
…
continue reading
1
In vitro gametogenesis: the science has to be right, and it has to be safe
16:46
16:46
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:46
Today’s podcast sees web editor Nicole Raleigh speak with Dr Mark Leondires, founder and medical director at Illume Fertility, who shares his own journey and insights on In vitro gametogenesis (IVG).Par pharmaphorum
…
continue reading
1
Proving ROI for digital endpoints
32:58
32:58
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:58
Jennifer Goldsack of DiME talks in this podcast about the ROI for digital endpoints for pharma. Data shows digital endpoints drives meaningful engagement with healthcare providers.Par pharmaphorum
…
continue reading
1
Clinical trials: their design, location, and, potentially, their simulation
17:09
17:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
17:09
Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.Par pharmaphorum
…
continue reading
1
Pace, acceleration, and precision are the name of the game
20:34
20:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
20:34
Security and privacy within biotech are critical points of consideration and discussion as the industry continues to innovate at speed, and it is such aspects that are central to today’s podcast with Zach Powers, chief information security officer at Benchling, the R&D cloud platform for the biotech industry.…
…
continue reading
1
Technology working as the puzzle piece to bring better outcomes to patients
18:28
18:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:28
While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise commercial strategy at Veeva Europe, about commercial strategy and digitalising commercial operations.Par pharmaphorum
…
continue reading
1
Is precision psychiatry possible?
35:38
35:38
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
35:38
On today’s podcast, host Jonah Comstock is joined by Dr Amit Etkin, founder and CEO of Alto Neuroscience, a recently IPO'd biotech that wants to bring precision medicine to psychiatry. But what do we mean when we talk about precision, especially in a discipline like mental health that has historically involved a lot of objectivity?…
…
continue reading
1
Encouraging early engagement to revitalise Europe’s pharmaceutical landscape
19:31
19:31
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:31
In an on-site interview at Reuters Pharma Europe in Barcelona, this week’s podcast saw Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discuss revitalising Europe’s pharmaceutical landscape and leveraging legislation for health and competitiveness.Par pharmaphorum
…
continue reading
1
Predictions for AI in mental health in the coming year
22:35
22:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
22:35
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.…
…
continue reading
1
Fixing clinical trial data management
26:34
26:34
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
26:34
It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it? On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.…
…
continue reading
1
Harnessing the velocity of biopharmaceutical advances
18:10
18:10
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:10
On today's episode of the podcast CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of technological advancements, including the buzzword artificial intelligence (AI) and machine learning when it comes to bioprocessing.Par pharmaphorum
…
continue reading
1
Conference report: Reuters Pharma USA
38:02
38:02
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
38:02
Last week, pharmaphorum Editor in Chief Jonah Comstock traveled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host and Deep Dive Editor Eloise McLellan about his biggest takeaways from the two-day event.Par pharmaphorum
…
continue reading
1
The future of AI: Machine learning working together with scientific expertise
10:28
10:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:28
In a new episode of the pharmaphorum podcast recorded live on site at WIRED Health in London in March, web editor Nicole Raleigh spoke with Elise de Reus, co-founder of Cradle, the generative AI platform that helps scientists to design and program proteins.Par pharmaphorum
…
continue reading
1
Understanding the politics of drug pricing in the United States
35:53
35:53
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
35:53
Everyone says they want more affordable drugs for patients that need them, but people disagree quite a bit on who's to blame for the current status quo of sky-high prescription prices – not to mention how they might be corrected. To help unpack some of those trends and conflicting perspectives, Brandon Newman, CEO of healthcare analytics firm Xevan…
…
continue reading
1
Female leadership and lessening disease burden
14:59
14:59
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:59
As Women’s History Month comes to its final week, today’s podcast sees web editor Nicole Raleigh in conversation with Debra Weiss, COO of the Bill & Melinda Gates Medical Research Institute (Gates MRI), discussing her role as a female leader in the leader and the non-profit organisation’s work in developing novel biomedical interventions and lessen…
…
continue reading
1
The unique clinical trial challenges faced by digital therapeutics
27:56
27:56
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
27:56
On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, cofounder of Lindus Health, a next-gen CRO that includes digital therapeutics among its specialties. They talk a little bit about often unseen difficulties of validating a digital therapeutic through a clinical trial.Par pharmaphorum
…
continue reading
1
The unmentionables: Challenging inequalities in women’s health
47:42
47:42
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
47:42
As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, but female leaders within life sciences, too. The guests included: Trine Bartholdy, chief innovation executive at the BioInnovation Institute (BII) in Denmark; Kar…
…
continue reading
1
The next chapter for AI protein structure prediction
28:01
28:01
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
28:01
On today’s pharmaphorum podcast, Glen Gowers, cofounder of Basecamp Research, gets into the company’s recent pre-print paper and how it improves upon AlphaFold 2, the current gold standard for protein folding prediction.Par pharmaphorum
…
continue reading
1
Avoiding the data swamp: The transformative power of AI
17:56
17:56
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
17:56
In the latest episode of the pharmaphorum podcast, host Nicole Raleigh speaks (virtually) with Nathan Clark, founder and CEO of Ganymede, a modern data platform and Cloud infrastructure for science, to discuss the evolving role of the Cloud in biopharma and some rather revolutionary tools in AI drug discovery.…
…
continue reading
1
How natural language processing can make a difference in pharma
22:32
22:32
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
22:32
On today’s podcast, host Jonah Comstock welcomes Jane Reed, director of life sciences at IQVIA NLP, the new name for recent IQVIA acquisition Linguamatics. Jane talks through some of these different technologies and use cases and describes how natural language processing has exciting potential in translating real-world conversations on social media…
…
continue reading
1
Transitioning from traditional surgical methods to the innovative use of stem cells.
18:35
18:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:35
In today’s podcast, host Nicole Raleigh welcomes Dr Jeffrey Gross, founder of ReCELLebrate, neurological surgeon, and expert in the field of regenerative medicine, to discuss this development. Their conversation delves into the recent appetite for the use of stem cells for longevity and explores the ‘health span’ notion that is being ever more freq…
…
continue reading